This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. We hypothesize that inherited variations of platelet adhesive glycoproteins determine platelet reactivity and hence, risk for acute ischemic coronary syndrome. Our long-term objective is to validate our hypothesis by measuring platelet function and performing platelet genotyping in patients who present with the acute coronary syndrome.
One specific aim of the project involves determining whether platelet aggregation may be used as a measure of platelet hyperfunction in patients with ischemic heart disease when compared to control subjects. Epinephrine threshold aggregation and whole blood flow cytometry using anti-receptor induced binding site binding will be performed at time of presentation with acute coronary syndrome and after 3-month interval. Comparison of platelet function studies performed at presentation and after a three-month interval will assess whether platelet function differs at the time of the acute event.
Specific aim 2 involves performing platelet genotyping in the patient group and comparing these frequencies to a control group of hospitalized patients.
Specific aim 3 involves correlating index events with platelet function and platelet glycoprotein polymorphism. Finally we will determine whether platelet function and/or platelet glycoprotein genotype can be used to predict subsequent events. If a correlation exists between genetic polymorphisms and the acute coronary syndrome, at risk individuals could be screened for these genetic polymorphisms. Future studies would be designed to evaluate whether targeting these individuals for aggressive preventive interventions or anti-platelet therapy would reduce risk of acute coronary events. The information obtained in this project could also lead to the design of newer medications used for the therapy of the acute coronary syndrome.
|Unick, Jessica L; Gaussoin, Sarah A; Hill, James O et al. (2017) Objectively Assessed Physical Activity and Weight Loss Maintenance among Individuals Enrolled in a Lifestyle Intervention. Obesity (Silver Spring) 25:1903-1909|
|Li, Tianjing; Wieland, L Susan; Oh, Esther et al. (2017) Design considerations of a randomized controlled trial of sedation level during hip fracture repair surgery: a strategy to reduce the incidence of postoperative delirium in elderly patients. Clin Trials 14:299-307|
|Sammut, Amanda; Shea, Steven; Blumenthal, Roger S et al. (2017) Albuminuria in Rheumatoid Arthritis: Associations With Rheumatoid Arthritis Characteristics and Subclinical Atherosclerosis. Arthritis Care Res (Hoboken) 69:1799-1808|
|Baker, Joshua F; Giles, Jon T; Weber, David et al. (2017) Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis. Rheumatology (Oxford) 56:981-988|
|Johnson, Karen C; Bray, George A; Cheskin, Lawrence J et al. (2017) The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial. J Bone Miner Res 32:2278-2287|
|Chao, Ariana M; Wadden, Thomas A; Gorin, Amy A et al. (2017) Binge Eating and Weight Loss Outcomes in Individuals with Type 2 Diabetes: 4-Year Results from the Look AHEAD Study. Obesity (Silver Spring) 25:1830-1837|
|Park, H-W; Tse, S; Yang, W et al. (2017) A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment. Pharmacogenomics J 17:180-185|
|Pownall, Henry J; Schwartz, Anne V; Bray, George A et al. (2016) Changes in regional body composition over 8 years in a randomized lifestyle trial: The look AHEAD study. Obesity (Silver Spring) 24:1899-905|
|Wing, Rena R; Espeland, Mark A; Clark, Jeanne M et al. (2016) Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial. Diabetes Care 39:1345-55|
|Unick, Jessica L; Gaussoin, Sarah A; Hill, James O et al. (2016) Four-Year Physical Activity Levels among Intervention Participants with Type 2 Diabetes. Med Sci Sports Exerc 48:2437-2445|
Showing the most recent 10 out of 406 publications